Cargando…
De novo mutational signature discovery in tumor genomes using SparseSignatures
Cancer is the result of mutagenic processes that can be inferred from tumor genomes by analyzing rate spectra of point mutations, or “mutational signatures”. Here we present SparseSignatures, a novel framework to extract signatures from somatic point mutation data. Our approach incorporates a user-s...
Autores principales: | Lal, Avantika, Liu, Keli, Tibshirani, Robert, Sidow, Arend, Ramazzotti, Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8270462/ https://www.ncbi.nlm.nih.gov/pubmed/34181655 http://dx.doi.org/10.1371/journal.pcbi.1009119 |
Ejemplares similares
-
SparseSignatures: An R package using LASSO-regularized non-negative matrix factorization to identify mutational signatures from human tumor samples
por: Mella, Lorenzo, et al.
Publicado: (2022) -
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
por: Lal, Avantika, et al.
Publicado: (2019) -
Multi-omic tumor data reveal diversity of molecular mechanisms that correlate with survival
por: Ramazzotti, Daniele, et al.
Publicado: (2018) -
A mixture model for signature discovery from sparse mutation data
por: Sason, Itay, et al.
Publicado: (2021) -
VirMutSig: Discovery and assignment of viral mutational signatures
from sequencing data
por: Maspero, Davide, et al.
Publicado: (2021)